{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:59:33Z","timestamp":1772006373782,"version":"3.50.1"},"reference-count":169,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:00:00Z","timestamp":1768003200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2024QC232"],"award-info":[{"award-number":["ZR2024QC232"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007129","name":"Natural Science Foundation of Shandong Province","doi-asserted-by":"publisher","award":["ZR2020MC020 (Yan Zhang)"],"award-info":[{"award-number":["ZR2020MC020 (Yan Zhang)"]}],"id":[{"id":"10.13039\/501100007129","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Histol"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1007\/s10735-025-10687-x","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T02:41:40Z","timestamp":1768012900000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Functional roles, mechanistic insights, and therapeutic potential of the IGF2BP family in viral infections and virus-associated cancers"],"prefix":"10.1007","volume":"57","author":[{"given":"Lufan","family":"Shen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengbin","family":"Lei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,1,10]]},"reference":[{"key":"10687_CR61","doi-asserted-by":"publisher","first-page":"e0035823","DOI":"10.1128\/mbio.00358-23","volume":"14","author":"SW Abdullah","year":"2023","unstructured":"Abdullah SW, Wu J, Wang X, Guo H, Sun S (2023) Advances and Breakthroughs in IRES-Directed Translation and Replication of Picornaviruses. mBio 14(2):e0035823. https:\/\/doi.org\/10.1128\/mbio.00358-23","journal-title":"mBio"},{"key":"10687_CR80","doi-asserted-by":"publisher","first-page":"8606","DOI":"10.1128\/jvi.00805-13","volume":"87","author":"MA Ansari","year":"2013","unstructured":"Ansari MA, Singh VV, Dutta S, Veettil MV, Dutta D, Chikoti L, Lu J, Everly D, Chandran B (2013) Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells. J Virol 87(15):8606-8623. https:\/\/doi.org\/10.1128\/jvi.00805-13","journal-title":"J Virol"},{"key":"10687_CR70","doi-asserted-by":"publisher","first-page":"1537","DOI":"10.1016\/j.biopha.2018.06.149","volume":"106","author":"RP Araldi","year":"2018","unstructured":"Araldi RP, Sant\u2019Ana TA, M\u00f3dolo DG, de Melo TC, Spadacci-Morena DD, de Cassia Stocco R, Cerutti JM, de Souza EB (2018) The human papillomavirus (HPV)-related cancer biology: An overview. Biomed Pharmacother 106:1537-1556. https:\/\/doi.org\/10.1016\/j.biopha.2018.06.149","journal-title":"Biomed Pharmacotherapy"},{"key":"10687_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1038\/s41568-020-0253-2","volume":"20","author":"I Barbieri","year":"2020","unstructured":"Barbieri I, Kouzarides T (2020) Role of RNA modifications in cancer. Nat Rev Cancer 20(6):303-322. https:\/\/doi.org\/10.1038\/s41568-020-0253-2","journal-title":"Nat Rev Cancer"},{"issue":"20","key":"10687_CR81","doi-asserted-by":"publisher","first-page":"5189","DOI":"10.3390\/cancers13205189","volume":"13","author":"M Bauer","year":"2021","unstructured":"Bauer M, Jasinski-Bergner S, Mandelboim O, Wickenhauser C, Seliger B (2021) Epstein-Barr Virus-Associated Malignancies and Immune Escape: The Role of the Tumor Microenvironment and Tumor Cell Evasion Strategies. Cancers (Basel) 13(20). https:\/\/doi.org\/10.3390\/cancers13205189","journal-title":"Cancers (Basel)"},{"key":"10687_CR11","doi-asserted-by":"publisher","first-page":"2657","DOI":"10.1007\/s00018-012-1186-z","volume":"70","author":"JL Bell","year":"2013","unstructured":"Bell JL, W\u00e4chter K, M\u00fchleck B, Pazaitis N, K\u00f6hn M, Lederer M, H\u00fcttelmaier S (2013) Insulin-like growth factor 2 mRNA-binding proteins (IGF2BPs): post-transcriptional drivers of cancer progression? Cell Mol Life Sci 70(15):2657-2675. https:\/\/doi.org\/10.1007\/s00018-012-1186-z","journal-title":"Cell Mol Life Sci"},{"key":"10687_CR159","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1146\/annurev-med-041217-010829","volume":"70","author":"CF Bennett","year":"2019","unstructured":"Bennett CF (2019) Therapeutic Antisense Oligonucleotides Are Coming of Age. Annu Rev Med 70:307-321. https:\/\/doi.org\/10.1146\/annurev-med-041217-010829","journal-title":"Annu Rev Med"},{"key":"10687_CR71","doi-asserted-by":"publisher","first-page":"103675","DOI":"10.1016\/j.critrevonc.2022.103675","volume":"174","author":"R Bhattacharjee","year":"2022","unstructured":"Bhattacharjee R, Das SS, Biswal SS, Nath A, Das D, Basu A, Malik S, Kumar L, Kar S, Singh SK, Upadhye VJ, Iqbal D, Almojam S, Roychoudhury S, Ojha S, Ruokolainen J, Jha NK, Kesari KK (2022) Mechanistic role of HPV-associated early proteins in cervical cancer: Molecular pathways and targeted therapeutic strategies. Crit Rev Oncol Hematol 174:103675. https:\/\/doi.org\/10.1016\/j.critrevonc.2022.103675","journal-title":"Crit Rev Oncol Hematol"},{"key":"10687_CR52","doi-asserted-by":"publisher","first-page":"4435","DOI":"10.1016\/j.ymthe.2024.10.025","volume":"32","author":"FF Chan","year":"2024","unstructured":"Chan FF, Kwan KK, Seoung DH et al (2024) N6-methyladenosine modification activates the Serine synthesis pathway to mediate therapeutic resistance in liver cancer. Mol Ther 32:4435\u20134447 https:\/\/doi.org\/10.1016\/j.ymthe.2024.10.025","journal-title":"Mol Ther"},{"key":"10687_CR67","doi-asserted-by":"publisher","first-page":"11704","DOI":"10.1128\/JVI.01474-13","volume":"87","author":"L Chatel-Chaix","year":"2013","unstructured":"Chatel-Chaix L, Germain MA, Motorina A, Bonneil \u00c9, Thibault P, Baril M, Lamarre D (2013) A host YB-1 ribonucleoprotein complex is hijacked by hepatitis C virus for the control of NS3-dependent particle production. J Virol 87(21):11704-11720. https:\/\/doi.org\/10.1128\/jvi.01474-13","journal-title":"J Virol"},{"key":"10687_CR19","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/978-3-030-57362-1_2","volume":"217","author":"CJ Chen","year":"2021","unstructured":"Chen CJ, You SL, Hsu WL, Yang HI, Lee MH, Chen HC, Chen YY, Liu J, Hu HH, Lin YJ, Chu YJ, Huang YT, Chiang CJ, Chien YC (2021) Epidemiology of Virus Infection and Human Cancer. Recent Results Cancer Res 217:13-45.  https:\/\/doi.org\/10.1007\/978-3-030-57362-1_2","journal-title":"Recent Results Cancer Res"},{"key":"10687_CR33","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1038\/s41419-023-06099-y","volume":"14","author":"L-J Chen","year":"2023","unstructured":"Chen L-J, Liu H-Y, Xiao Z-Y, Qiu T, Zhang D, Zhang L-J, Han F-Y, Chen G-J, Xu X-M, Zhu J-H, Ding Y-Q, Wang S-Y, Ye Y-P, Jiao H-L (2023a) IGF2BP3 promotes the progression of colorectal cancer and mediates cetuximab resistance by stabilizing EGFR mRNA in an m6A-dependent manner. Cell Death & Disease 14(9):581.  https:\/\/doi.org\/10.1038\/s41419-023-06099-y","journal-title":"Cell Death Dis"},{"key":"10687_CR104","doi-asserted-by":"publisher","first-page":"3564","DOI":"10.1038\/s41388-023-02865-6","volume":"42","author":"B Chen","year":"2023","unstructured":"Chen B, Huang R, Xia T, Wang C, Xiao X, Lu S, Chen X, Ouyang Y, Deng X, Miao J, Zhao C, Wang L (2023b) The m6A reader IGF2BP3 preserves NOTCH3 mRNA stability to sustain Notch3 signaling and promote tumor metastasis in nasopharyngeal carcinoma. Oncogene 42(48):3564-3574. https:\/\/doi.org\/10.1038\/s41388-023-02865-6 https:\/\/doi.org\/10.1038\/s41388-023-02865-6","journal-title":"Oncogene"},{"key":"10687_CR64","doi-asserted-by":"publisher","first-page":"2621","DOI":"10.1007\/s00018-012-0940-6","volume":"69","author":"JC Cheng","year":"2012","unstructured":"Cheng JC, Yeh YJ, Tseng CP, Hsu SD, Chang YL, Sakamoto N, Huang HD (2012) Let-7b is a novel regulator of hepatitis C virus replication. Cell Mol Life Sci 69(15):2621-2633. https:\/\/doi.org\/10.1007\/s00018-012-0940-6","journal-title":"Cell Mol Life Sci"},{"key":"10687_CR65","doi-asserted-by":"publisher","first-page":"9707","DOI":"10.1128\/JVI.00802-13","volume":"87","author":"M Cheng","year":"2013","unstructured":"Cheng M, Si Y, Niu Y, Liu X, Li X, Zhao J, Jin Q, Yang W (2013) High-Throughput Profiling of Alpha Interferon- and Interleukin-28B-Regulated MicroRNAs and Identification of let-7s with Anti-Hepatitis C Virus Activity by Targeting IGF2BP1. Journal of Virology 87(17):9707-9718.","journal-title":"J Virol"},{"issue":"4","key":"10687_CR58","doi-asserted-by":"publisher","first-page":"376","DOI":"10.3390\/cells8040376","volume":"8","author":"DI Chigbu","year":"2019","unstructured":"Chigbu DI, Loonawat R, Sehgal M, Patel D, Jain P (2019) Hepatitis C Virus Infection: Host\u207bVirus Interaction and Mechanisms of Viral Persistence. Cells 8(4). https:\/\/doi.org\/10.3390\/cells8040376","journal-title":"Cells"},{"key":"10687_CR114","doi-asserted-by":"publisher","first-page":"10473","DOI":"10.1128\/jvi.76.20.10473-10484.2002","volume":"76","author":"D Cmarko","year":"2002","unstructured":"Cmarko D, B\u00f8e SO, Scassellati C, Szilvay AM, Davanger S, Fu XD, Haukenes G, Kalland KH, Fakan S (2002) Rev inhibition strongly affects intracellular distribution of human immunodeficiency virus type 1 RNAs. J Virol 76(20):10473-10484. https:\/\/doi.org\/10.1128\/jvi.76.20.10473-10484.2002","journal-title":"J Virol"},{"key":"10687_CR30","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1101\/gad.2042311","volume":"25","author":"N Dai","year":"2011","unstructured":"Dai N, Rapley J, Angel M, Yanik MF, Blower MD, Avruch J (2011) mTOR phosphorylates IMP2 to promote IGF2 mRNA translation by internal ribosomal entry. Genes Dev 25(11):1159-1172. https:\/\/doi.org\/10.1101\/gad.2042311","journal-title":"Genes Dev"},{"key":"10687_CR77","doi-asserted-by":"publisher","first-page":"3652","DOI":"10.1016\/j.cell.2022.08.026","volume":"185","author":"B Damania","year":"2022","unstructured":"Damania B, Kenney SC, Raab-Traub N (2022) Epstein-Barr virus: Biology and clinical disease. Cell 185(20):3652-3670. https:\/\/doi.org\/10.1016\/j.cell.2022.08.026","journal-title":"Cell"},{"issue":"1","key":"10687_CR22","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3390\/ncrna5010007","volume":"5","author":"ND Damas","year":"2019","unstructured":"Damas ND, Fossat N, Scheel TKH (2019) Functional Interplay between RNA Viruses and Non-Coding RNA in Mammals. Noncoding RNA 5(1). https:\/\/doi.org\/10.3390\/ncrna5010007","journal-title":"Noncoding RNA"},{"key":"10687_CR109","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.3201\/eid2706.210284","volume":"27","author":"KM De Cock","year":"2021","unstructured":"De Cock KM, Jaffe HW, Curran JW (2021) Reflections on 40 Years of AIDS. Emerg Infect Dis 27(6):1553-1560. https:\/\/doi.org\/10.3201\/eid2706.210284","journal-title":"Emerg Infect Dis"},{"key":"10687_CR51","doi-asserted-by":"publisher","first-page":"1480","DOI":"10.1002\/hep.31850","volume":"74","author":"Wb Ding","year":"2021","unstructured":"Ding Wb, Wang Mc, Yu J, Huang G, Sun Dp, Liu L, Zhang Jn, Yang Y, Liu H, Zhou Wp, Yang F, Yuan Sx (2021) HBV\/Pregenomic RNA Increases the Stemness and Promotes the Development of HBV\u2010Related HCC Through Reciprocal Regulation With Insulin\u2010Like Growth Factor 2 mRNA\u2010Binding Protein 3. Hepatology 74(3):1480-1495. https:\/\/doi.org\/10.1002\/hep.31850","journal-title":"Hepatology"},{"key":"10687_CR86","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1111\/cas.16047","volume":"115","author":"N Ding","year":"2023","unstructured":"Ding N, Cao G, Wang Z, Xu S, Chen W (2023) Tumor suppressive function of IGF2BP1 in gastric cancer through decreasing MYC. Cancer Science 115(2):427-438. https:\/\/doi.org\/10.1111\/cas.16047","journal-title":"Cancer Sci"},{"key":"10687_CR29","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1038\/nature11112","volume":"485","author":"D Dominissini","year":"2012","unstructured":"Dominissini D, Moshitch-Moshkovitz S, Schwartz S, Salmon-Divon M, Ungar L, Osenberg S, Cesarkas K, Jacob-Hirsch J, Amariglio N, Kupiec M, Sorek R, Rechavi G (2012) Topology of the human and mouse m6A RNA methylomes revealed by m6A-seq. Nature 485(7397):201-206. https:\/\/doi.org\/10.1038\/nature11112","journal-title":"Nature"},{"key":"10687_CR146","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1186\/s12951-024-02582-6","volume":"22","author":"FL Dong","year":"2024","unstructured":"Dong FL, Xu ZZ, Wang YQ, Li T, Wang X, Li J (2024) Exosome-derived circUPF2 enhances resistance to targeted therapy by redeploying ferroptosis sensitivity in hepatocellular carcinoma. J Nanobiotechnology 22(1):298. https:\/\/doi.org\/10.1186\/s12951-024-02582-6","journal-title":"J Nanobiotechnol"},{"key":"10687_CR13","doi-asserted-by":"publisher","first-page":"5036","DOI":"10.1093\/nar\/26.22.5036","volume":"26","author":"GA Doyle","year":"1998","unstructured":"Doyle GA, Betz NA, Leeds PF, Fleisig AJ, Prokipcak RD, Ross J (1998) The c-myc coding region determinant-binding protein: a member of a family of KH domain RNA-binding proteins. Nucleic Acids Res 26(22):5036-5044. https:\/\/doi.org\/10.1093\/nar\/26.22.5036","journal-title":"Nucleic Acids Res"},{"key":"10687_CR1","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/nrm760","volume":"3","author":"G Dreyfuss","year":"2002","unstructured":"Dreyfuss G, Kim VN, Kataoka N (2002) Messenger-RNA-binding proteins and the messages they carry. Nat Rev Mol Cell Biol 3(3):195-205. https:\/\/doi.org\/10.1038\/nrm760","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10687_CR103","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1038\/s41420-022-00844-6","volume":"8","author":"M Du","year":"2022","unstructured":"Du M, Peng Y, Li Y, Sun W, Zhu H, Wu J, Zong D, Wu L, He X (2022a) MYC-activated RNA N6-methyladenosine reader IGF2BP3 promotes cell proliferation and metastasis in nasopharyngeal carcinoma. Cell Death Discov 8(1):53. https:\/\/doi.org\/10.1038\/s41420-022-00844-6","journal-title":"Cell Death Discov"},{"key":"10687_CR130","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1186\/s12943-022-01575-z","volume":"21","author":"A Du","year":"2022","unstructured":"Du A, Li S, Zhou Y, Disoma C, Liao Y, Zhang Y, Chen Z, Yang Q, Liu P, Liu S, Dong Z, Razzaq A, Tao S, Chen X, Liu Y, Xu L, Zhang Q, Li S, Peng J, Xia Z (2022b) M6A-mediated upregulation of circMDK promotes tumorigenesis and acts as a nanotherapeutic target in hepatocellular carcinoma. Mol Cancer 21(1):109. https:\/\/doi.org\/10.1186\/s12943-022-01575-z","journal-title":"Mol Cancer"},{"key":"10687_CR48","doi-asserted-by":"publisher","first-page":"4942","DOI":"10.7150\/ijbs.112133","volume":"21","author":"Z-B Du","year":"2025","unstructured":"Du Z-B, Wu X-M, Han T et al (2025)\u2009malat1\u2009promotes malignancy of hbv-related hepatocellular carcinoma by regulating igf2bp3-mediated nuclear-cytoplasmic shuttling. Int J Biol Sci 21:4942\u20134960","journal-title":"Int J Biol Sci"},{"key":"10687_CR131","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1186\/s12943-022-01537-5","volume":"21","author":"JL Duan","year":"2022","unstructured":"Duan JL, Chen W, Xie JJ, Zhang ML, Nie RC, Liang H, Mei J, Han K, Xiang ZC, Wang FW, Teng K, Chen RX, Deng MH, Yin YX, Zhang N, Xie D, Cai MY (2022) A novel peptide encoded by N6-methyladenosine modified circMAP3K4 prevents apoptosis in hepatocellular carcinoma. Mol Cancer 21(1):93. https:\/\/doi.org\/10.1186\/s12943-022-01537-5","journal-title":"Mol Cancer"},{"issue":"20","key":"10687_CR32","doi-asserted-by":"publisher","first-page":"11118","DOI":"10.3390\/ijms252011118","volume":"25","author":"M Fakhar","year":"2024","unstructured":"Fakhar M, Gul M, Li W (2024) Interactive Structural Analysis of KH3-4 Didomains of IGF2BPs with Preferred RNA Motif Having m(6)A Through Dynamics Simulation Studies. Int J Mol Sci 25(20). https:\/\/doi.org\/10.3390\/ijms252011118","journal-title":"Int J Mol Sci"},{"key":"10687_CR121","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1016\/j.febslet.2015.06.038","volume":"589","author":"IO Fawzy","year":"2015","unstructured":"Fawzy IO, Hamza MT, Hosny KA, Esmat G, El Tayebi HM, Abdelaziz AI (2015) miR-1275: A single microRNA that targets the three IGF2-mRNA-binding proteins hindering tumor growth in hepatocellular carcinoma. FEBS Lett 589(17):2257-2265. https:\/\/doi.org\/10.1016\/j.febslet.2015.06.038","journal-title":"FEBS Lett"},{"key":"10687_CR7","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1016\/j.gendis.2022.08.018","volume":"10","author":"L Feng","year":"2023","unstructured":"Feng L, Du R, Chang B, Li M, Tian J, Wang S (2023) Multilevel regulation of N(6)-methyladenosine RNA modifications: Implications in tumorigenesis and therapeutic opportunities. Genes Dis 10(5):1969-1981. https:\/\/doi.org\/10.1016\/j.gendis.2022.08.018","journal-title":"Genes Dis"},{"key":"10687_CR119","doi-asserted-by":"publisher","first-page":"1815","DOI":"10.1097\/QAD.0000000000000366","volume":"28","author":"MA Frasco","year":"2014","unstructured":"Frasco MA, Karim R, Van Den Berg D, Watanabe RM, Anastos K, Cohen M, Gange SJ, Gustafson DR, Liu C, Tien PC, Mack WJ, Pearce CL (2014) Antiretroviral therapy modifies the genetic effect of known type 2 diabetes-associated risk variants in HIV-infected women. AIDS 28(12):1815-1823. https:\/\/doi.org\/10.1097\/qad.0000000000000366","journal-title":"AIDS"},{"key":"10687_CR168","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/s13045-023-01485-7","volume":"16","author":"DJ Fu","year":"2023","unstructured":"Fu DJ, Wang T (2023) Targeting NEDD8-activating enzyme for cancer therapy: developments, clinical trials, challenges and future research directions. J Hematol Oncol 16(1):87. https:\/\/doi.org\/10.1186\/s13045-023-01485-7","journal-title":"J Hematol Oncol"},{"key":"10687_CR123","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.3892\/ol.2020.11693","volume":"20","author":"Y Gao","year":"2020","unstructured":"Gao Y, Luo T, Ouyang X, Zhu C, Zhu J, Qin X (2020) IGF2BP3 and miR191-5p synergistically increase HCC cell invasiveness by altering ZO-1 expression. Oncol Lett 20(2):1423-1431. https:\/\/doi.org\/10.3892\/ol.2020.11693","journal-title":"Oncol Lett"},{"issue":"3","key":"10687_CR85","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/s41419-024-06566-0","volume":"15","author":"L Ge","year":"2024","unstructured":"Ge L, Rui Y, Wang C, Wu Y, Wang H, Wang J (2024) The RNA m6A reader IGF2BP3 regulates NFAT1\/IRF1 axis-mediated anti-tumor activity in gastric cancer. Cell Death & Disease 15(3). https:\/\/doi.org\/10.1038\/s41419-024-06566-0","journal-title":"Cell Death Dis"},{"key":"10687_CR44","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/0092-8674(80)90443-2","volume":"21","author":"WH Gerlich","year":"1980","unstructured":"Gerlich WH, Robinson WS (1980) Hepatitis B virus contains protein attached to the 5' terminus of its complete DNA strand. Cell 21(3):801-809. https:\/\/doi.org\/10.1016\/0092-8674(80)90443-2","journal-title":"Cell"},{"issue":"7","key":"10687_CR25","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.3390\/v15071431","volume":"15","author":"M Gla\u00df","year":"2023","unstructured":"Gla\u00df M, H\u00fcttelmaier S (2023) IGF2BP1-An Oncofetal RNA-Binding Protein Fuels Tumor Virus Propagation. Viruses 15(7). https:\/\/doi.org\/10.3390\/v15071431","journal-title":"Viruses"},{"key":"10687_CR118","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1186\/s12943-023-01827-6","volume":"22","author":"A Glaviano","year":"2023","unstructured":"Glaviano A, Foo ASC, Lam HY et al. (2023) PI3K\/AKT\/mTOR signaling transduction pathway and targeted therapies in cancer. Mol Cancer 22(1):138.  https:\/\/doi.org\/10.1186\/s12943-023-01827-6","journal-title":"Mol Cancer"},{"key":"10687_CR78","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.coviro.2021.11.013","volume":"52","author":"R Guo","year":"2022","unstructured":"Guo R, Gewurz BE (2022) Epigenetic control of the Epstein-Barr lifecycle. Current Opinion in Virology 52:78-88.","journal-title":"Curr Opin Virol"},{"key":"10687_CR107","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1038\/s41590-021-00898-1","volume":"22","author":"H Guo","year":"2021","unstructured":"Guo H, Wang Q, Ghneim K, Wang L, Rampanelli E, Holley-Guthrie E, Cheng L, Garrido C, Margolis DM, Eller LA, Robb ML, Sekaly RP, Chen X, Su L, Ting JP (2021) Multi-omics analyses reveal that HIV-1 alters CD4(+) T cell immunometabolism to fuel virus replication. Nat Immunol 22(4):423-433. https:\/\/doi.org\/10.1038\/s41590-021-00898-1","journal-title":"Nat Immunol"},{"key":"10687_CR37","doi-asserted-by":"crossref","unstructured":"Guo J, Li K, Ming Y, Pan Y, Tan S, Ma H, Chen S, Duan Y, Peng Y (2025) A circular RNA overcomes acquired resistance to BET inhibitors by antagonizing IGF2BP2-mediated c-MYC translation in TNBC. Proceedings of the National Academy of Sciences 122(27):e2504320122.","DOI":"10.1073\/pnas.2504320122"},{"key":"10687_CR120","doi-asserted-by":"publisher","first-page":"121075","DOI":"10.1016\/j.lfs.2022.121075","volume":"310","author":"DA Habashy","year":"2022","unstructured":"Habashy DA, Hamad MHM, Ragheb M, Khalil ZA, El Sobky SA, Hosny KA, Esmat G, El-Ekiaby N, Fawzy IO, Abdelaziz AI (2022) Regulation of IGF2BP1 by miR-186 and its impact on downstream lncRNAs H19, FOXD2-AS1, and SNHG3 in HCC. Life Sci 310:121075. https:\/\/doi.org\/10.1016\/j.lfs.2022.121075","journal-title":"Life Sci"},{"key":"10687_CR49","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1002\/hep.29463","volume":"67","author":"B Halgand","year":"2018","unstructured":"Halgand B, Desterke C, Rivi\u00e8re L, Fallot G, Sebagh M, Calderaro J, Bioulac-Sage P, Neuveut C, Buendia MA, Samuel D, F\u00e9ray C (2018) Hepatitis B Virus Pregenomic RNA in Hepatocellular Carcinoma: A Nosological and Prognostic Determinant. Hepatology 67(1):86-96. https:\/\/doi.org\/10.1002\/hep.29463","journal-title":"Hepatology"},{"key":"10687_CR128","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/j.ncrna.2024.03.012","volume":"9","author":"GS Hama Faraj","year":"2024","unstructured":"Hama Faraj GS, Hussen BM, Abdullah SR, Fatih Rasul M, Hajiesmaeili Y, Baniahmad A, Taheri M (2024) Advanced approaches of the use of circRNAs as a replacement for cancer therapy. Noncoding RNA Res 9(3):811-830. https:\/\/doi.org\/10.1016\/j.ncrna.2024.03.012","journal-title":"Noncoding RNA Res"},{"key":"10687_CR14","doi-asserted-by":"publisher","first-page":"4448","DOI":"10.1128\/MCB.24.10.4448-4464.2004","volume":"24","author":"TV Hansen","year":"2004","unstructured":"Hansen TV, Hammer NA, Nielsen J, Madsen M, Dalbaeck C, Wewer UM, Christiansen J, Nielsen FC (2004) Dwarfism and impaired gut development in insulin-like growth factor II mRNA-binding protein 1-deficient mice. Mol Cell Biol 24(10):4448-4464. https:\/\/doi.org\/10.1128\/mcb.24.10.4448-4464.2004","journal-title":"Mol Cell Biol"},{"key":"10687_CR126","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.bbrc.2019.07.058","volume":"517","author":"H He","year":"2019","unstructured":"He H, Wu W, Sun Z, Chai L (2019) MiR-4429 prevented gastric cancer progression through targeting METTL3 to inhibit m6A-caused stabilization of SEC62. Biochemical and Biophysical Research Communications 517(4):581-587. https:\/\/doi.org\/10.1016\/j.bbrc.2019.07.058","journal-title":"Biochem Biophys Res Commun"},{"key":"10687_CR133","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1038\/s41392-021-00569-5","volume":"6","author":"AT He","year":"2021","unstructured":"He AT, Liu J, Li F, Yang BB (2021) Targeting circular RNAs as a therapeutic approach: current strategies and challenges. Signal Transduction and Targeted Therapy 6(1):185. https:\/\/doi.org\/10.1038\/s41392-021-00569-5","journal-title":"Signal Transduct Target Therapy"},{"key":"10687_CR72","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1016\/j.tim.2017.07.007","volume":"26","author":"K Hoppe-Seyler","year":"2018","unstructured":"Hoppe-Seyler K, Bossler F, Braun JA, Herrmann AL, Hoppe-Seyler F (2018) The HPV E6\/E7 Oncogenes: Key Factors for Viral Carcinogenesis and Therapeutic Targets. Trends Microbiol 26(2):158-168. https:\/\/doi.org\/10.1016\/j.tim.2017.07.007","journal-title":"Trends Microbiol"},{"key":"10687_CR158","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/s41392-020-0207-x","volume":"5","author":"B Hu","year":"2020","unstructured":"Hu B, Zhong L, Weng Y, Peng L, Huang Y, Zhao Y, Liang XJ (2020) Therapeutic siRNA: state of the art. Signal Transduct Target Ther 5(1):101. https:\/\/doi.org\/10.1038\/s41392-020-0207-x","journal-title":"Signal Transduct Target Ther"},{"key":"10687_CR75","doi-asserted-by":"publisher","first-page":"507","DOI":"10.7150\/ijbs.67770","volume":"18","author":"C Hu","year":"2022","unstructured":"Hu C, Liu T, Han C, Xuan Y, Jiang D, Sun Y, Zhang X, Zhang W, Xu Y, Liu Y, Pan J, Wang J, Fan J, Che Y, Huang Y, Zhang J, Ding J, Yang S, Yang K (2022) HPV E6\/E7 promotes aerobic glycolysis in cervical cancer by regulating IGF2BP2 to stabilize m6A-MYC expression. International Journal of Biological Sciences 18(2):507-521. https:\/\/doi.org\/10.7150\/ijbs.67770","journal-title":"Int J Biol Sci"},{"key":"10687_CR132","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1186\/s12935-023-03168-2","volume":"23","author":"P Hu","year":"2023","unstructured":"Hu P, Lin L, Huang T, Li Z, Xiao M, Guo H, Chen G, Liu D, Ke M, Shan H, Zhang F, Zhang Y (2023a) Circular RNA circEYA3 promotes the radiation resistance of hepatocellular carcinoma via the IGF2BP2\/DTX3L axis. Cancer Cell Int 23(1):308. https:\/\/doi.org\/10.1186\/s12935-023-03168-2","journal-title":"Cancer Cell Int"},{"key":"10687_CR139","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12943-023-01759-1","volume":"22","author":"Z Hu","year":"2023","unstructured":"Hu Z, Chen G, Zhao Y, Gao H, Li L, Yin Y, Jiang J, Wang L, Mang Y, Gao Y, Zhang S, Ran J, Li L (2023b) Exosome-derived circCCAR1 promotes CD8\u2009+\u2009T-cell dysfunction and anti-PD1 resistance in hepatocellular carcinoma. Mol Cancer 22(1):55. https:\/\/doi.org\/10.1186\/s12943-023-01759-1","journal-title":"Mol Cancer"},{"key":"10687_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1038\/s41556-018-0045-z","volume":"20","author":"H Huang","year":"2018","unstructured":"Huang H, Weng H, Sun W et al. (2018) Recognition of RNA N(6)-methyladenosine by IGF2BP proteins enhances mRNA stability and translation. Nat Cell Biol 20(3):285-295. https:\/\/doi.org\/10.1038\/s41556-018-0045-z","journal-title":"Nat Cell Biol"},{"key":"10687_CR157","doi-asserted-by":"publisher","first-page":"103569","DOI":"10.1016\/j.sjbs.2023.103569","volume":"30","author":"A Jamal","year":"2023","unstructured":"Jamal A, Hassan Dalhat M, Jahan S, Choudhry H, Imran Khan M (2023) BTYNB, an inhibitor of RNA binding protein IGF2BP1 reduces proliferation and induces differentiation of leukemic cancer cells. Saudi J Biol Sci 30(3):103569. https:\/\/doi.org\/10.1016\/j.sjbs.2023.103569","journal-title":"Saudi J Biol Sci"},{"key":"10687_CR89","doi-asserted-by":"publisher","first-page":"21650","DOI":"10.1016\/j.canlet.2023.216510","volume":"581","author":"T Jiang","year":"2024","unstructured":"Jiang T, Xia Y, Li Y, Lu C, Lin J, Shen Y, Lv J, Xie L, Gu C, Xu Z, Wang L (2024a) TRIM29 promotes antitumor immunity through enhancing IGF2BP1 ubiquitination and subsequent PD-L1 downregulation in gastric cancer. Cancer Letters 581. https:\/\/doi.org\/10.1016\/j.canlet.2023.216510","journal-title":"Cancer Lett"},{"key":"10687_CR142","doi-asserted-by":"publisher","first-page":"102090","DOI":"10.1016\/j.tranon.2024.102090","volume":"49","author":"W Jiang","year":"2024","unstructured":"Jiang W, Wang Y, He W, Wang P, Meng P, Zhang S (2024b) CircCOCH plays a critical role in Hepatocellular carcinoma through modulating miR-450a and activating PI3K\/mTOR pathway. Transl Oncol 49:102090. https:\/\/doi.org\/10.1016\/j.tranon.2024.102090","journal-title":"Transl Oncol"},{"key":"10687_CR23","doi-asserted-by":"publisher","first-page":"104709","DOI":"10.1016\/j.antiviral.2020.104709","volume":"175","author":"E Jo","year":"2020","unstructured":"Jo E, Ryu D-K, K\u00f6nig A, Park S, Cho Y, Park S-H, Kim T-H, Yoon SK, Ryu W-S, Cechetto J, Windisch MP (2020) Identification and characterization of a novel hepatitis B virus pregenomic RNA encapsidation inhibitor. Antiviral Research 175:104709. https:\/\/doi.org\/10.1016\/j.antiviral.2020.104709","journal-title":"Antiviral Res"},{"issue":"1","key":"10687_CR111","doi-asserted-by":"publisher","first-page":"152","DOI":"10.3390\/v14010152","volume":"14","author":"S Kalinichenko","year":"2022","unstructured":"Kalinichenko S, Komkov D, Mazurov D (2022) HIV-1 and HTLV-1 Transmission Modes: Mechanisms and Importance for Virus Spread. Viruses 14(1). https:\/\/doi.org\/10.3390\/v14010152","journal-title":"Viruses"},{"key":"10687_CR115","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1038\/ncb1638","volume":"9","author":"M Kanai","year":"2007","unstructured":"Kanai M, Hanashiro K, Kim SH, Hanai S, Boulares AH, Miwa M, Fukasawa K (2007) Inhibition of Crm1-p53 interaction and nuclear export of p53 by poly(ADP-ribosyl)ation. Nat Cell Biol 9(10):1175-1183. https:\/\/doi.org\/10.1038\/ncb1638","journal-title":"Nat Cell Biol"},{"issue":"4","key":"10687_CR21","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3390\/ph16040485","volume":"16","author":"M Kandeel","year":"2023","unstructured":"Kandeel M (2023) Oncogenic Viruses-Encoded microRNAs and Their Role in the Progression of Cancer: Emerging Targets for Antiviral and Anticancer Therapies. Pharmaceuticals (Basel) 16(4). https:\/\/doi.org\/10.3390\/ph16040485","journal-title":"Pharmaceuticals (Basel)"},{"key":"10687_CR163","doi-asserted-by":"publisher","first-page":"7405","DOI":"10.1158\/1078-0432.CCR-19-1490","volume":"25","author":"S Laban","year":"2019","unstructured":"Laban S, Gangkofner DS, Holzinger D et al. (2019) Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients. Clin Cancer Res 25(24):7405-7412. https:\/\/doi.org\/10.1158\/1078-0432.Ccr-19-1490","journal-title":"Clin Cancer Res"},{"key":"10687_CR63","doi-asserted-by":"publisher","first-page":"7199","DOI":"10.1128\/jvi.00225-14","volume":"88","author":"Y Li","year":"2014","unstructured":"Li Y, Masaki T, Shimakami T, Lemon SM, Williams B (2014) hnRNP L and NF90 Interact with Hepatitis C Virus 5\u2032-Terminal Untranslated RNA and Promote Efficient Replication. Journal of Virology 88(13):7199-7209. https:\/\/doi.org\/10.1128\/jvi.00225-14","journal-title":"J Virol"},{"key":"10687_CR59","doi-asserted-by":"publisher","first-page":"3527","DOI":"10.3748\/wjg.v25.i27.3527","volume":"25","author":"TY Li","year":"2019","unstructured":"Li TY, Yang Y, Zhou G, Tu ZK (2019) Immune suppression in chronic hepatitis B infection associated liver disease: A review. World J Gastroenterol 25(27):3527-3537. https:\/\/doi.org\/10.3748\/wjg.v25.i27.3527","journal-title":"World J Gastroenterol"},{"key":"10687_CR5","doi-asserted-by":"publisher","first-page":"104142","DOI":"10.1016\/j.ebiom.2022.104142","volume":"82","author":"HB Li","year":"2022","unstructured":"Li HB, Huang G, Tu J, Lv DM, Jin QL, Chen JK, Zou YT, Lee DF, Shen JN, Xie XB (2022) METTL14-mediated epitranscriptome modification of MN1 mRNA promote tumorigenicity and all-trans-retinoic acid resistance in osteosarcoma. EBioMedicine 82:104142. https:\/\/doi.org\/10.1016\/j.ebiom.2022.104142","journal-title":"EBioMedicine"},{"key":"10687_CR39","doi-asserted-by":"publisher","first-page":"2916","DOI":"10.1111\/jgh.16765","volume":"39","author":"Y Li","year":"2024","unstructured":"Li Y, Chen L, Li S, Song H, Chen Y, Wang S (2024a) The m6A reader IGF2BP1 contributes to the activation of hepatic stellate cells through facilitating TUBB4B mRNA stabilization. J Gastroenterol Hepatol 39(12):2916-2925. https:\/\/doi.org\/10.1111\/jgh.16765","journal-title":"J Gastroenterol Hepatol"},{"key":"10687_CR100","doi-asserted-by":"publisher","first-page":"e1766","DOI":"10.1002\/ctm2.1766","volume":"14","author":"L Li","year":"2024","unstructured":"Li L, Tang Q, Ge J, Wang D, Mo Y, Zhang Y, Wang Y, Xiong F, Yan Q, Liao Q, Guo C, Wang F, Zhou M, Xiang B, Zeng Z, Shi L, Chen P, Xiong W (2024b) METTL14 promotes lipid metabolism reprogramming and sustains nasopharyngeal carcinoma progression via enhancing m(6)A modification of ANKRD22 mRNA. Clin Transl Med 14(7):e1766. https:\/\/doi.org\/10.1002\/ctm2.1766","journal-title":"Clin Transl Med"},{"key":"10687_CR105","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s13402-024-01016-7","volume":"47","author":"Q Li","year":"2024","unstructured":"Li Q, Liu J, Zeng C, Qin D, Zhang Z, Lv Q, Li J, Huang W (2024c) HNRNPH1 stabilizes FLOT2 mRNA in a non-canonical m6A-dependent manner to promote malignant progression in nasopharyngeal carcinoma. Cell Oncol (Dordr) 47(6):2279-2295. https:\/\/doi.org\/10.1007\/s13402-024-01016-7","journal-title":"Cell Oncol (Dordr)"},{"key":"10687_CR42","doi-asserted-by":"publisher","first-page":"S13","DOI":"10.1002\/hep.22881","volume":"49","author":"TJ Liang","year":"2009","unstructured":"Liang TJ (2009) Hepatitis B: the virus and disease. Hepatology 49(5 Suppl):S13-21. https:\/\/doi.org\/10.1002\/hep.22881","journal-title":"Hepatology"},{"key":"10687_CR79","doi-asserted-by":"publisher","first-page":"e1011939","DOI":"10.1371\/journal.ppat.1011939","volume":"20","author":"Y Liao","year":"2024","unstructured":"Liao Y, Yan J, Beri NR, Giulino-Roth L, Cesarman E, Gewurz BE (2024) Germinal center cytokine driven epigenetic control of Epstein-Barr virus latency gene expression. PLoS Pathog 20(4):e1011939. https:\/\/doi.org\/10.1371\/journal.ppat.1011939","journal-title":"PLoS Pathog"},{"issue":"2","key":"10687_CR50","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1128\/JCM.01275-19","volume":"58","author":"N Lin","year":"2020","unstructured":"Lin N, Ye A, Lin J, Liu C, Huang J, Fu Y, Wu S, Xu S, Wang L, Ou Q (2020) Diagnostic Value of Detection of Pregenomic RNA in Sera of Hepatitis B Virus-Infected Patients with Different Clinical Outcomes. J Clin Microbiol 58(2). https:\/\/doi.org\/10.1128\/jcm.01275-19","journal-title":"J Clin Microbiol"},{"key":"10687_CR57","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1038\/nature04077","volume":"436","author":"BD Lindenbach","year":"2005","unstructured":"Lindenbach BD, Rice CM (2005) Unravelling hepatitis C virus replication from genome to function. Nature 436(7053):933-938. https:\/\/doi.org\/10.1038\/nature04077","journal-title":"Nature"},{"key":"10687_CR46","doi-asserted-by":"publisher","first-page":"e1670","DOI":"10.1038\/cddis.2015.46","volume":"6","author":"FY Liu","year":"2015","unstructured":"Liu FY, Zhou SJ, Deng YL, Zhang ZY, Zhang EL, Wu ZB, Huang ZY, Chen XP (2015) MiR-216b is involved in pathogenesis and progression of hepatocellular carcinoma through HBx-miR-216b-IGF2BP2 signaling pathway. Cell Death Dis 6(3):e1670. https:\/\/doi.org\/10.1038\/cddis.2015.46","journal-title":"Cell Death Dis"},{"key":"10687_CR129","doi-asserted-by":"publisher","first-page":"8023","DOI":"10.2147\/cmar.S218967","volume":"11","author":"Q Liu","year":"2019","unstructured":"Liu Q, Shuai M, Xia Y (2019) Knockdown of EBV-encoded circRNA circRPMS1 suppresses nasopharyngeal carcinoma cell proliferation and metastasis through sponging multiple miRNAs. Cancer Manag Res 11:8023-8031. https:\/\/doi.org\/10.2147\/cmar.S218967","journal-title":"Cancer Manag Res"},{"key":"10687_CR150","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1158\/0008-5472.Can-20-0554","volume":"81","author":"J Liu","year":"2021","unstructured":"Liu J, Jiang X, Zou A, Mai Z, Huang Z, Sun L, Zhao J (2021) circIGHG-Induced Epithelial-to-Mesenchymal Transition Promotes Oral Squamous Cell Carcinoma Progression via miR-142-5p\/IGF2BP3 Signaling. Cancer Res 81(2):344-355. https:\/\/doi.org\/10.1158\/0008-5472.Can-20-0554","journal-title":"Cancer Res"},{"key":"10687_CR83","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellsig.2022.110313","author":"Liu","year":"2022","unstructured":"Liu D, Xia AD, Wu L-P, Li S, Zhang K, Chen D (2022a) IGF2BP2 promotes gastric cancer progression by regulating the IGF1R-RhoA-ROCK signaling pathway. Cellular Signalling 94. https:\/\/doi.org\/10.1016\/j.cellsig.2022.110313","journal-title":"Cellular Signalling"},{"key":"10687_CR164","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1021\/acscentsci.2c00107","volume":"8","author":"Y Liu","year":"2022","unstructured":"Liu Y, Guo Q, Yang H, Zhang XW, Feng N, Wang JK, Liu TT, Zeng KW, Tu PF (2022b) Allosteric Regulation of IGF2BP1 as a Novel Strategy for the Activation of Tumor Immune Microenvironment. ACS Cent Sci 8(8):1102-1115. https:\/\/doi.org\/10.1021\/acscentsci.2c00107","journal-title":"ACS Cent Sci"},{"key":"10687_CR16","doi-asserted-by":"publisher","first-page":"7421","DOI":"10.1038\/s41467-024-51634-w","volume":"15","author":"C Liu","year":"2024","unstructured":"Liu C, Dou X, Zhao Y, Zhang L, Zhang L, Dai Q, Liu J, Wu T, Xiao Y, He C (2024a) IGF2BP3 promotes mRNA degradation through internal m(7)G modification. Nat Commun 15(1):7421. https:\/\/doi.org\/10.1038\/s41467-024-51634-w","journal-title":"Nat Commun"},{"key":"10687_CR38","doi-asserted-by":"publisher","first-page":"135989","DOI":"10.1016\/j.ijbiomac.2024.135989","volume":"280","author":"Z Liu","year":"2024","unstructured":"Liu Z, Deng K, Su Y, Zhang Z, Shi C, Wang J, Fan Y, Zhang G, Wang F (2024b) IGF2BP1-mediated the stability and protein translation of FGFR1 mRNA regulates myogenesis through the ERK signaling pathway. Int J Biol Macromol 280:135989. https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.135989","journal-title":"Int J Biol Macromol"},{"key":"10687_CR66","doi-asserted-by":"publisher","first-page":"e00522","DOI":"10.1128\/jvi.00522-24","volume":"98","author":"J Liu","year":"2024","unstructured":"Liu J, Ito M, Liu L, Nakashima K, Satoh S, Konno A, Suzuki T (2024c) Involvement of ribosomal protein L17 and Y-box binding protein 1 in the assembly of hepatitis C virus potentially via their interaction with the 3\u2019 untranslated region of the viral genome. Journal of Virology 98(7):e00522-00524","journal-title":"J Virol"},{"key":"10687_CR99","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41698-024-00747-y","volume":"8","author":"H Liu","year":"2024","unstructured":"Liu H, Li Y, Tang L, Sun X, Xie W, Xiao T, Gu W, Yang H, Wang H, Chen P (2024d) UBR5 metabolically reprograms nasopharyngeal carcinoma cells to promote glycolysis and M2 polarization via SPLUNC1 signaling. NPJ Precis Oncol 8(1):252. https:\/\/doi.org\/10.1038\/s41698-024-00747-y","journal-title":"NPJ Precis Oncol"},{"key":"10687_CR166","doi-asserted-by":"publisher","first-page":"4243","DOI":"10.1111\/odi.14864","volume":"30","author":"L Liu","year":"2024","unstructured":"Liu L, Zhao T, Zheng S, Tang D, Han H, Yang C, Zheng X, Wang J, Ma J, Wei W, Wang Z, He S, He Q (2024e) METTL3 inhibitor STM2457 impairs tumor progression and enhances sensitivity to anlotinib in OSCC. Oral Dis 30(7):4243-4254. https:\/\/doi.org\/10.1111\/odi.14864","journal-title":"Oral Dis"},{"key":"10687_CR28","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1186\/s11658-025-00723-9","volume":"30","author":"S Liu","year":"2025","unstructured":"Liu S, Liao S, He J, Zhou Y, He Q (2025a) IGF2BP2: an m6A reader that affects cellular function and disease progression. Cell Mol Biol Lett 30(1):43. https:\/\/doi.org\/10.1186\/s11658-025-00723-9","journal-title":"Cell Mol Biology Lett"},{"key":"10687_CR167","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12951-024-03021-2","volume":"23","author":"C Liu","year":"2025","unstructured":"Liu C, Fan D, Sun J, Li G, Du R, Zuo X, Zhang K, Zhang W, Wang S, Li X, Du M, Wang D, Hao Q, Zhang Y, Li M, Zhang C, Gao Y (2025b) Inhibition of METTL14 overcomes CDK4\/6 inhibitor resistance driven by METTL14-m6A-E2F1-axis in ER\u03b1-positive breast cancer. J Nanobiotechnology 23(1):3. https:\/\/doi.org\/10.1186\/s12951-024-03021-2","journal-title":"J Nanobiotechnol"},{"key":"10687_CR134","doi-asserted-by":"publisher","first-page":"114826","DOI":"10.1016\/j.addr.2023.114826","volume":"197","author":"T Loan Young","year":"2023","unstructured":"Loan Young T, Chang Wang K, James Varley A, Li B (2023) Clinical delivery of circular RNA: Lessons learned from RNA drug development. Advanced Drug Delivery Reviews 197:114826. https:\/\/doi.org\/10.1016\/j.addr.2023.114826","journal-title":"Adv Drug Deliv Rev"},{"issue":"1","key":"10687_CR143","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1186\/s13046-022-02466-3","volume":"41","author":"Q Ma","year":"2022","unstructured":"Ma Q, Yang F, Huang B, Pan X, Li W, Yu T, Wang X, Ran L, Qian K, Li H, Li H, Liu Y, Liang C, Ren J, Zhang Y, Wang S, Xiao B (2022) CircARID1A binds to IGF2BP3 in gastric cancer and promotes cancer proliferation by forming a circARID1A-IGF2BP3-SLC7A5 RNA\u2013protein ternary complex. Journal of Experimental & Clinical Cancer Research 41(1). https:\/\/doi.org\/10.1186\/s13046-022-02466-3","journal-title":"J Experimental Clin Cancer Res"},{"key":"10687_CR27","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s10020-024-00936-2","volume":"30","author":"S Ma","year":"2024","unstructured":"Ma S, Qin Y, Ren W (2024) Insulin-like growth factor 2 mRNA-binding protein 1 (IGF2BP1) in hematological diseases. Mol Med 30(1):165. https:\/\/doi.org\/10.1186\/s10020-024-00936-2","journal-title":"Mol Med"},{"key":"10687_CR155","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1016\/j.tranon.2017.07.008","volume":"10","author":"L Mahapatra","year":"2017","unstructured":"Mahapatra L, Andruska N, Mao C, Le J, Shapiro DJ (2017) A Novel IMP1 Inhibitor, BTYNB, Targets c-Myc and Inhibits Melanoma and Ovarian Cancer Cell Proliferation. Transl Oncol 10(5):818-827. https:\/\/doi.org\/10.1016\/j.tranon.2017.07.008","journal-title":"Transl Oncol"},{"key":"10687_CR108","doi-asserted-by":"publisher","first-page":"105410","DOI":"10.1016\/j.ebiom.2024.105410","volume":"109","author":"MH Marichannegowda","year":"2024","unstructured":"Marichannegowda MH, Setua S, Bose M et al. (2024) Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotype. EBioMedicine 109:105410.  https:\/\/doi.org\/10.1016\/j.ebiom.2024.105410","journal-title":"EBioMedicine"},{"issue":"14","key":"10687_CR112","doi-asserted-by":"publisher","first-page":"7569","DOI":"10.3390\/ijms23147569","volume":"23","author":"V Marie","year":"2022","unstructured":"Marie V, Gordon ML (2022) The HIV-1 Gag Protein Displays Extensive Functional and Structural Roles in Virus Replication and Infectivity. Int J Mol Sci 23(14). https:\/\/doi.org\/10.3390\/ijms23147569","journal-title":"Int J Mol Sci"},{"issue":"10","key":"10687_CR106","doi-asserted-by":"publisher","first-page":"1351","DOI":"10.3390\/cells12101351","volume":"12","author":"SK Masenga","year":"2023","unstructured":"Masenga SK, Mweene BC, Luwaya E, Muchaili L, Chona M, Kirabo A (2023) HIV-Host Cell Interactions. Cells 12(10). https:\/\/doi.org\/10.3390\/cells12101351","journal-title":"Cells"},{"key":"10687_CR110","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1093\/cid\/ciu094","volume":"58","author":"H Masur","year":"2014","unstructured":"Masur H, Brooks JT, Benson CA, Holmes KK, Pau AK, Kaplan JE (2014) Prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: Updated Guidelines from the Centers for Disease Control and Prevention, National Institutes of Health, and HIV Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis 58(9):1308-1311. https:\/\/doi.org\/10.1093\/cid\/ciu094","journal-title":"Clin Infect Dis"},{"key":"10687_CR152","doi-asserted-by":"publisher","first-page":"RP94347","DOI":"10.7554\/eLife.94347.3","volume":"13","author":"C Mazeaud","year":"2024","unstructured":"Mazeaud C, Pfister S, Owen JE, Pereira HS, Charbonneau F, Robinson ZE, Anton A, Bemis CL, Sow AA, Patel TR, Neufeldt CJ, Scaturro P, Chatel-Chaix L (2024) Zika virus remodels and hijacks IGF2BP2 ribonucleoprotein complex to promote viral replication organelle biogenesis. eLife 13:RP94347. https:\/\/doi.org\/10.7554\/eLife.94347","journal-title":"eLife"},{"key":"10687_CR147","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1186\/s13062-024-00571-1","volume":"19","author":"Q Meng","year":"2024","unstructured":"Meng Q, Xiang H, Wang Y, Hu K, Luo X, Wang J, Chen E, Zhang W, Chen J, Chen X, Wang H, Ju Z, Song Z (2024) Exosomes containing circSCP2 in colorectal cancer promote metastasis via sponging miR-92a-1-5p and interacting with PTBP1 to stabilize IGF2BP1. Biol Direct 19(1):130. https:\/\/doi.org\/10.1186\/s13062-024-00571-1","journal-title":"Biol Direct"},{"issue":"1","key":"10687_CR116","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1186\/1742-4690-7-41","volume":"7","author":"MP Milev","year":"2010","unstructured":"Milev MP, Brown CM, Mouland AJ (2010) Live cell visualization of the interactions between HIV-1 Gag and the cellular RNA-binding protein Staufen1. Retrovirology 7(1). https:\/\/doi.org\/10.1186\/1742-4690-7-41","journal-title":"Retrovirology"},{"key":"10687_CR12","doi-asserted-by":"publisher","first-page":"2172","DOI":"10.1158\/0008-5472.CAN-10-3295","volume":"71","author":"PS Mongroo","year":"2011","unstructured":"Mongroo PS, Noubissi FK, Cuatrecasas M, Kalabis J, King CE, Johnstone CN, Bowser MJ, Castells A, Spiegelman VS, Rustgi AK (2011) IMP-1 displays cross-talk with K-Ras and modulates colon cancer cell survival through the novel proapoptotic protein CYFIP2. Cancer Res 71(6):2172-2182. https:\/\/doi.org\/10.1158\/0008-5472.Can-10-3295","journal-title":"Cancer Res"},{"key":"10687_CR18","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1146\/annurev-virology-111821-103721","volume":"11","author":"PS Moore","year":"2024","unstructured":"Moore PS, Chang Y (2024) Are There More Human Cancer Viruses Left to Be Found? Annu Rev Virol 11(1):239-259.  https:\/\/doi.org\/10.1146\/annurev-virology-111821-103721","journal-title":"Annu Rev Virol"},{"key":"10687_CR31","doi-asserted-by":"publisher","first-page":"6285","DOI":"10.1093\/nar\/gky229","volume":"46","author":"S M\u00fcller","year":"2018","unstructured":"M\u00fcller S, Bley N, Gla\u00df M, Busch B, Rousseau V, Misiak D, Fuchs T, Lederer M, H\u00fcttelmaier S (2018) IGF2BP1 enhances an aggressive tumor cell phenotype by impairing miRNA-directed downregulation of oncogenic factors. Nucleic Acids Res 46(12):6285-6303. https:\/\/doi.org\/10.1093\/nar\/gky229","journal-title":"Nucleic Acids Res"},{"key":"10687_CR153","doi-asserted-by":"publisher","first-page":"8576","DOI":"10.1093\/nar\/gkaa653","volume":"48","author":"S M\u00fcller","year":"2020","unstructured":"M\u00fcller S, Bley N, Busch B, Gla\u00df M, Lederer M, Misiak C, Fuchs T, Wedler A, Haase J, Bertoldo JB, Michl P, H\u00fcttelmaier S (2020) The oncofetal RNA-binding protein IGF2BP1 is a druggable, post-transcriptional super-enhancer of E2F-driven gene expression in cancer. Nucleic Acids Res 48(15):8576-8590. https:\/\/doi.org\/10.1093\/nar\/gkaa653","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"10687_CR91","doi-asserted-by":"publisher","first-page":"1982","DOI":"10.1038\/s41598-021-81667-w","volume":"11","author":"H Nakano","year":"2021","unstructured":"Nakano H, Saito M, Nakajima S, Saito K, Nakayama Y, Kase K, Yamada L, Kanke Y, Hanayama H, Onozawa H, Okayama H, Fujita S, Sakamoto W, Saze Z, Momma T, Mimura K, Ohki S, Goto A, Kono K (2021) PD-L1 overexpression in EBV-positive gastric cancer is caused by unique genomic or epigenomic mechanisms. Scientific Reports 11(1). https:\/\/doi.org\/10.1038\/s41598-021-81667-w","journal-title":"Sci Rep"},{"key":"10687_CR68","doi-asserted-by":"publisher","first-page":"200258","DOI":"10.1016\/j.tvr.2023.200258","volume":"15","author":"CW Nelson","year":"2023","unstructured":"Nelson CW, Mirabello L (2023) Human papillomavirus genomics: Understanding carcinogenicity. Tumour Virus Res 15:200258. https:\/\/doi.org\/10.1016\/j.tvr.2023.200258","journal-title":"Tumour Virus Res"},{"key":"10687_CR26","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1128\/MCB.19.2.1262","volume":"19","author":"J Nielsen","year":"1999","unstructured":"Nielsen J, Christiansen J, Lykke-Andersen J, Johnsen AH, Wewer UM, Nielsen FC (1999) A family of insulin-like growth factor II mRNA-binding proteins represses translation in late development. Mol Cell Biol 19(2):1262-1270. https:\/\/doi.org\/10.1128\/mcb.19.2.1262","journal-title":"Mol Cell Biol"},{"key":"10687_CR82","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/2042-4280-2-1","volume":"2","author":"S Ning","year":"2011","unstructured":"Ning S (2011) Innate immune modulation in EBV infection. Herpesviridae 2(1):1. https:\/\/doi.org\/10.1186\/2042-4280-2-1","journal-title":"Herpesviridae"},{"key":"10687_CR145","doi-asserted-by":"publisher","first-page":"e994","DOI":"10.1002\/ctm2.994","volume":"12","author":"X Pan","year":"2022","unstructured":"Pan X, Huang B, Ma Q, Ren J, Liu Y, Wang C, Zhang D, Fu J, Ran L, Yu T, Li H, Wang X, Yang F, Liang C, Zhang Y, Wang S, Ren J, Li W, Wang Y, Xiao B (2022) Circular RNA circ-TNPO3 inhibits clear cell renal cell carcinoma metastasis by binding to IGF2BP2 and destabilizing SERPINH1 mRNA. Clin Transl Med 12(7):e994. https:\/\/doi.org\/10.1002\/ctm2.994","journal-title":"Clin Transl Med"},{"issue":"3","key":"10687_CR56","doi-asserted-by":"publisher","first-page":"36291","DOI":"10.31083\/fbl36291","volume":"30","author":"W Pan","year":"2025","unstructured":"Pan W, Wu X, Yu L, Zhang J (2025) Small Extracellular Vesicles Promote HBV Replication via METTL3\u2013IGF2BP2-Mediated m6A Modification. Frontiers in Bioscience-Landmark 30(3). https:\/\/doi.org\/10.31083\/fbl36291","journal-title":"Front Bioscience-Landmark"},{"key":"10687_CR20","doi-asserted-by":"publisher","first-page":"e0063521","DOI":"10.1128\/mBio.00635-21","volume":"12","author":"A Pant","year":"2021","unstructured":"Pant A, Dsouza L, Yang Z (2021) Alteration in Cellular Signaling and Metabolic Reprogramming during Viral Infection. mBio 12(5):e0063521. https:\/\/doi.org\/10.1128\/mBio.00635-21","journal-title":"mBio"},{"key":"10687_CR60","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1038\/334320a0","volume":"334","author":"J Pelletier","year":"1988","unstructured":"Pelletier J, Sonenberg N (1988) Internal initiation of translation of eukaryotic mRNA directed by a sequence derived from poliovirus RNA. Nature 334(6180):320-325. https:\/\/doi.org\/10.1038\/334320a0","journal-title":"Nature"},{"key":"10687_CR124","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1111\/jop.13156","volume":"50","author":"L Qiu","year":"2021","unstructured":"Qiu L, Zheng L, Gan C, Deng W, Sun Y, Wang T (2021) circBICD2 targets miR-149-5p\/IGF2BP1 axis to regulate oral squamous cell carcinoma progression. J Oral Pathol Med 50(7):668-680. https:\/\/doi.org\/10.1111\/jop.13156","journal-title":"J Oral Pathol Med"},{"key":"10687_CR8","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1186\/s13045-022-01224-4","volume":"15","author":"J Qu","year":"2022","unstructured":"Qu J, Yan H, Hou Y, Cao W, Liu Y, Zhang E, He J, Cai Z (2022) RNA demethylase ALKBH5 in cancer: from mechanisms to therapeutic potential. J Hematol Oncol 15(1):8. https:\/\/doi.org\/10.1186\/s13045-022-01224-4","journal-title":"J Hematol Oncol"},{"key":"10687_CR148","doi-asserted-by":"publisher","first-page":"2671","DOI":"10.1007\/s11010-023-04692-5","volume":"478","author":"A Ren","year":"2023","unstructured":"Ren A, Gong F, Liu G, Fan W (2023) NR1H4-mediated circRHOBTB3 modulates the proliferation, metastasis, and Warburg effects of cervical cancer through interacting with IGF2BP3. Mol Cell Biochem 478(12):2671-2681. https:\/\/doi.org\/10.1007\/s11010-023-04692-5","journal-title":"Mol Cell Biochem"},{"key":"10687_CR135","doi-asserted-by":"publisher","first-page":"e1002680","DOI":"10.1371\/journal.ppat.1002680","volume":"8","author":"CC Rossetto","year":"2012","unstructured":"Rossetto CC, Pari G (2012) KSHV PAN RNA associates with demethylases UTX and JMJD3 to activate lytic replication through a physical interaction with the virus genome. PLoS Pathog 8(5):e1002680. https:\/\/doi.org\/10.1371\/journal.ppat.1002680","journal-title":"PLoS Pathog"},{"key":"10687_CR154","doi-asserted-by":"publisher","first-page":"zcaf006","DOI":"10.1093\/narcan\/zcaf006","volume":"7","author":"A Schott","year":"2025","unstructured":"Schott A, Simon T, M\u00fcller S et al. (2025) The IGF2BP1 oncogene is a druggable m(6)A-dependent enhancer of YAP1-driven gene expression in ovarian cancer. NAR Cancer 7(1):zcaf006. https:\/\/doi.org\/10.1093\/narcan\/zcaf006","journal-title":"NAR Cancer"},{"key":"10687_CR162","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1080\/14786419.2017.1366478","volume":"32","author":"YM Shaalan","year":"2018","unstructured":"Shaalan YM, Handoussa H, Youness RA, Assal RA, El-Khatib AH, Linscheid MW, El Tayebi HM, Abdelaziz AI (2018) Destabilizing the interplay between miR-1275 and IGF2BPs by Tamarix articulata and quercetin in hepatocellular carcinoma. Nat Prod Res 32(18):2217-2220.  https:\/\/doi.org\/10.1080\/14786419.2017.1366478","journal-title":"Nat Prod Res"},{"key":"10687_CR117","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/s13046-023-02810-1","volume":"42","author":"G Sharma","year":"2023","unstructured":"Sharma G, Tran TM, Bansal I, Beg MS, Bhardwaj R, Bassi J, Tan Y, Jaiswal AK, Tso C, Jain A, Singh J, Chattopadhyay P, Singh A, Chopra A, Bakhshi S, Casero D, Rao DS, Palanichamy JK (2023) RNA binding protein IGF2BP1 synergizes with ETV6-RUNX1 to drive oncogenic signaling in B-cell Acute Lymphoblastic Leukemia. J Exp Clin Cancer Res 42(1):231. https:\/\/doi.org\/10.1186\/s13046-023-02810-1","journal-title":"J Exp Clin Cancer Res"},{"key":"10687_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.apsb.2025.08.013","author":"X Su","year":"2025","unstructured":"Su X, Zang J, Wang Y, Zhang S, Wu P, Chen W, Shi L, Wu Y, Deng D, Cai K, Mai H, Xu A, Lu D (2025) IGF2BP1 positively regulates CircOGDH accumulation in hypoxia induced stress granules. Acta Pharmaceutica Sinica B. https:\/\/doi.org\/10.1016\/j.apsb.2025.08.013","journal-title":"Acta Pharm Sinica B"},{"key":"10687_CR125","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1097\/CAD.0000000000001479","volume":"34","author":"G Sun","year":"2023","unstructured":"Sun G, Tian J, Xiao Y, Zeng Y (2023) Circular RNA circ_0005667 promotes cisplatin resistance of endometrial carcinoma cells by regulating IGF2BP1 through miR-145-5p. Anticancer Drugs 34(7):816-826. https:\/\/doi.org\/10.1097\/cad.0000000000001479","journal-title":"Anticancer Drugs"},{"key":"10687_CR161","doi-asserted-by":"publisher","unstructured":"Talib WH, Awajan D, Alqudah A, Alsawwaf R, Althunibat R, Abu AlRoos M, Al Safadi A, Abu Asab S, Hadi RW, Al Kury LT (2024) Targeting Cancer Hallmarks with Epigallocatechin Gallate (EGCG): Mechanistic Basis and Therapeutic Targets. Molecules 29(6). https:\/\/doi.org\/10.3390\/molecules29061373","DOI":"10.3390\/molecules29061373"},{"key":"10687_CR88","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1007\/s12033-023-00896-8","volume":"66","author":"B Tang","year":"2023","unstructured":"Tang B, Bi L, Xu Y, Cao L, Li X (2023) N6-Methyladenosine (m6A) Reader IGF2BP1 Accelerates Gastric Cancer Development and Immune Escape by Targeting PD-L1. Molecular Biotechnology 66(10):2850-2859. https:\/\/doi.org\/10.1007\/s12033-023-00896-8","journal-title":"Mol Biotechnol"},{"key":"10687_CR17","doi-asserted-by":"publisher","first-page":"753366","DOI":"10.3389\/fviro.2021.753366","volume":"1","author":"I Tempera","year":"2021","unstructured":"Tempera I, Lieberman PM (2021) Oncogenic Viruses as Entropic Drivers of Cancer Evolution. Front Virol 1. https:\/\/doi.org\/10.3389\/fviro.2021.753366","journal-title":"Front Virol"},{"issue":"6","key":"10687_CR76","doi-asserted-by":"publisher","first-page":"13864","DOI":"10.1111\/1440-1681.13864","volume":"51","author":"Q Tian","year":"2024","unstructured":"Tian Q, Huang J, Zhang Q, Zhao J (2024) N6\u2010methyladenosine methylation on FSCN1 mediated by METTL14\/IGF2BP3 contributes to human papillomavirus type 16\u2010infected cervical squamous cell carcinoma. Clinical and Experimental Pharmacology and Physiology 51(6). https:\/\/doi.org\/10.1111\/1440-1681.13864","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10687_CR43","doi-asserted-by":"publisher","first-page":"S4","DOI":"10.1016\/j.jhep.2016.01.027","volume":"64","author":"S Tong","year":"2016","unstructured":"Tong S, Revill P (2016) Overview of hepatitis B viral replication and genetic variability. J Hepatol 64:S4\u2013S16. https:\/\/doi.org\/10.1016\/j.jhep.2016.01.027","journal-title":"J Hepatol"},{"key":"10687_CR95","doi-asserted-by":"publisher","unstructured":"Tsao SW, Tsang CM, Lo KW (2017) Epstein-Barr virus infection and nasopharyngeal carcinoma. Philos Trans R Soc Lond B Biol Sci 372(1732). https:\/\/doi.org\/10.1098\/rstb.2016.0270","DOI":"10.1098\/rstb.2016.0270"},{"key":"10687_CR137","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.3389\/fonc.2019.01120","volume":"9","author":"RJA Verhoeven","year":"2019","unstructured":"Verhoeven RJA, Tong S, Mok BW, Liu J, He S, Zong J, Chen Y, Tsao SW, Lung ML, Chen H (2019) Epstein-Barr Virus BART Long Non-coding RNAs Function as Epigenetic Modulators in Nasopharyngeal Carcinoma. Front Oncol 9:1120. https:\/\/doi.org\/10.3389\/fonc.2019.01120","journal-title":"Front Oncol"},{"key":"10687_CR160","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1038\/s41388-025-03449-2","volume":"44","author":"N Wallis","year":"2025","unstructured":"Wallis N, Gershon T, Shaaby S, Oberman F, Grunewald M, Duran D, Singh A, Vainer G, Spiegelman VS, Sharma AK, Yisraeli JK (2025) AVJ16 inhibits lung carcinoma by targeting IGF2BP1. Oncogene 44(35):3239-3254. https:\/\/doi.org\/10.1038\/s41388-025-03449-2","journal-title":"Oncogene"},{"key":"10687_CR55","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.3389\/fphys.2018.01918","volume":"9","author":"AA Waly","year":"2018","unstructured":"Waly AA, El-Ekiaby N, Assal RA, Abdelrahman MM, Hosny KA, El Tayebi HM, Esmat G, Breuhahn K, Abdelaziz AI (2018) Methylation in MIRLET7A3 Gene Induces the Expression of IGF-II and Its mRNA Binding Proteins IGF2BP-2 and 3 in Hepatocellular Carcinoma. Front Physiol 9:1918. https:\/\/doi.org\/10.3389\/fphys.2018.01918","journal-title":"Front Physiol"},{"key":"10687_CR84","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1136\/gutjnl-2019-319639","volume":"69","author":"Q Wang","year":"2020","unstructured":"Wang Q, Chen C, Ding Q, Zhao Y, Wang Z, Chen J, Jiang Z, Zhang Y, Xu G, Zhang J, Zhou J, Sun B, Zou X, Wang S (2020) METTL3-mediated m(6)A modification of HDGF mRNA promotes gastric cancer progression and has prognostic significance. Gut 69(7):1193-1205. https:\/\/doi.org\/10.1136\/gutjnl-2019-319639","journal-title":"Gut"},{"key":"10687_CR138","doi-asserted-by":"publisher","first-page":"198217","DOI":"10.1016\/j.virusres.2020.198217","volume":"291","author":"H Wang","year":"2021","unstructured":"Wang H, Liu W, Luo B (2021) The roles of miRNAs and lncRNAs in Epstein-Barr virus associated epithelial cell tumors. Virus Research 291:198217. https:\/\/doi.org\/10.1016\/j.virusres.2020.198217","journal-title":"Virus Res"},{"key":"10687_CR2","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1016\/j.semcancer.2022.03.018","volume":"86","author":"S Wang","year":"2022","unstructured":"Wang S, Sun Z, Lei Z, Zhang HT (2022a) RNA-binding proteins and cancer metastasis. Semin Cancer Biol 86(Pt 2):748-768. https:\/\/doi.org\/10.1016\/j.semcancer.2022.03.018","journal-title":"Semin Cancer Biol"},{"key":"10687_CR74","doi-asserted-by":"crossref","unstructured":"Wang L, Zhan G, Maimaitiyiming Y, Su Y, Lin S, Liu J, Su K, Lin J, Shen S, He W, Wang F, Chen J, Sun S, Xue Y, Gu J, Chen X, Zhang J, Zhang L, Wang Q, Chang K-J, Chiou S-H, Bj\u00f6rklund M, Naranmandura H, Cheng X, Hsu C-H (2022b) m6A modification confers thermal vulnerability to HPV E7 oncotranscripts via reverse regulation of its reader protein IGF2BP1 upon heat stress. Cell Reports 41(4)","DOI":"10.1016\/j.celrep.2022.111546"},{"key":"10687_CR92","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1038\/s41467-022-28479-2","volume":"13","author":"J Wang","year":"2022","unstructured":"Wang J, Ge J, Wang Y et al. (2022c) EBV miRNAs BART11 and BART17-3p promote immune escape through the enhancer-mediated transcription of PD-L1. Nat Commun 13(1):866. https:\/\/doi.org\/10.1038\/s41467-022-28479-2","journal-title":"Nat Commun"},{"key":"10687_CR156","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1186\/s40164-023-00429-8","volume":"12","author":"JJ Wang","year":"2023","unstructured":"Wang JJ, Chen DX, Zhang Y, Xu X, Cai Y, Wei WQ, Hao JJ, Wang MR (2023a) Elevated expression of the RNA-binding protein IGF2BP1 enhances the mRNA stability of INHBA to promote the invasion and migration of esophageal squamous cancer cells. Exp Hematol Oncol 12(1):75. https:\/\/doi.org\/10.1186\/s40164-023-00429-8","journal-title":"Exp Hematol Oncol"},{"key":"10687_CR165","doi-asserted-by":"publisher","first-page":"216122","DOI":"10.1016\/j.canlet.2023.216122","volume":"559","author":"L Wang","year":"2023","unstructured":"Wang L, Yang Q, Zhou Q, Fang F, Lei K, Liu Z, Zheng G, Zhu L, Huo J, Li X, Peng S, Kuang M, Lin S, Huang M, Xu L (2023b) METTL3-m(6)A-EGFR-axis drives lenvatinib resistance in hepatocellular carcinoma. Cancer Lett 559:216122. https:\/\/doi.org\/10.1016\/j.canlet.2023.216122","journal-title":"Cancer Lett"},{"key":"10687_CR62","doi-asserted-by":"publisher","first-page":"1528","DOI":"10.1261\/rna.1578409","volume":"15","author":"S Weinlich","year":"2009","unstructured":"Weinlich S, H\u00fcttelmaier S, Schierhorn A, Behrens S-E, Ostareck-Lederer A, Ostareck DH (2009) IGF2BP1 enhances HCV IRES-mediated translation initiation via the 3\u2032UTR. RNA 15(8):1528-1542. https:\/\/doi.org\/10.1261\/rna.1578409","journal-title":"RNA"},{"key":"10687_CR40","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1016\/j.ccell.2022.10.004","volume":"40","author":"H Weng","year":"2022","unstructured":"Weng H, Huang F, Yu Z et al. (2022) The m(6)A reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell 40(12):1566-1582.e1510. https:\/\/doi.org\/10.1016\/j.ccell.2022.10.004","journal-title":"Cancer Cell"},{"key":"10687_CR136","doi-asserted-by":"publisher","first-page":"e1007389","DOI":"10.1371\/journal.ppat.1007389","volume":"14","author":"JB Withers","year":"2018","unstructured":"Withers JB, Li ES, Vallery TK, Yario TA, Steitz JA (2018) Two herpesviral noncoding PAN RNAs are functionally homologous but do not associate with common chromatin loci. PLoS Pathog 14(11):e1007389. https:\/\/doi.org\/10.1371\/journal.ppat.1007389","journal-title":"PLoS Pathog"},{"key":"10687_CR69","doi-asserted-by":"publisher","first-page":"e2537","DOI":"10.1002\/rmv.2537","volume":"34","author":"J Wolf","year":"2024","unstructured":"Wolf J, Kist LF, Pereira SB, Quessada MA, Petek H, Pille A, Maccari JG, Mutlaq MP, Nasi LA (2024) Human papillomavirus infection: Epidemiology, biology, host interactions, cancer development, prevention, and therapeutics. Rev Med Virol 34(3):e2537. https:\/\/doi.org\/10.1002\/rmv.2537","journal-title":"Rev Med Virol"},{"key":"10687_CR10","doi-asserted-by":"publisher","first-page":"1003808","DOI":"10.3389\/fonc.2022.1003808","volume":"12","author":"K Wu","year":"2022","unstructured":"Wu K, Chang F, Li W, Su T, Lei D (2022) Role of IGF2BPs in head and neck squamous cell carcinoma. Front Oncol 12:1003808. https:\/\/doi.org\/10.3389\/fonc.2022.1003808","journal-title":"Front Oncol"},{"key":"10687_CR127","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s41389-020-0215-2","volume":"9","author":"J Xiao","year":"2020","unstructured":"Xiao J, Lin L, Luo D, Shi L, Chen W, Fan H, Li Z, Ma X, Ni P, Yang L, Xu Z (2020) Long noncoding RNA TRPM2-AS acts as a microRNA sponge of miR-612 to promote gastric cancer progression and radioresistance. Oncogenesis 9(3). https:\/\/doi.org\/10.1038\/s41389-020-0215-2","journal-title":"Oncogenesis"},{"key":"10687_CR169","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s10020-025-01095-8","volume":"31","author":"DD Xiong","year":"2025","unstructured":"Xiong DD, Chen ZD, Li JD, Deng YL, He RQ, Huang ZG, An SQ, Dang YW, Chen G (2025) Nitidine chloride inhibits the progression of hepatocellular carcinoma by suppressing IGF2BP3 and modulates metabolic pathways in an m(6)A-dependent manner. Mol Med 31(1):47. https:\/\/doi.org\/10.1186\/s10020-025-01095-8","journal-title":"Mol Med"},{"key":"10687_CR101","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/jcmm.17093","volume":"26","author":"Y Xu","year":"2022","unstructured":"Xu Y, Guo Z, Peng H, Guo L, Wang P (2022) IGF2BP3 promotes cell metastasis and is associated with poor patient survival in nasopharyngeal carcinoma. J Cell Mol Med 26(2):410-421. https:\/\/doi.org\/10.1111\/jcmm.17093","journal-title":"J Cell Mol Med"},{"key":"10687_CR87","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1002\/ctm2.1505","volume":"13","author":"YY Xu","year":"2023","unstructured":"Xu YY, Li T, Shen A, Bao XQ, Lin JF, Guo LZ, Meng Q, Ruan DY, Zhang QH, Zuo ZX, Zeng Zl (2023) FTO up\u2010regulation induced by MYC suppresses tumour progression in Epstein\u2012Barr virus\u2010associated gastric cancer. Clinical and Translational Medicine 13(12). https:\/\/doi.org\/10.1002\/ctm2.1505","journal-title":"Clin Translational Med"},{"key":"10687_CR53","doi-asserted-by":"publisher","first-page":"e70356","DOI":"10.1002\/jmv.70356","volume":"97","author":"X Xu","year":"2025","unstructured":"Xu X, Zhang Y, Wu S, Wu Y, Lin X, Chen K, Lin X (2025a) Hepatitis B Virus Promotes Angiogenesis in Hepatocellular Carcinoma by Increasing m6A Modification of VEGFA mRNA via IGF2BP3. J Med Virol 97(5):e70356. https:\/\/doi.org\/10.1002\/jmv.70356","journal-title":"J Med Virol"},{"key":"10687_CR149","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12943-025-02239-4","volume":"24","author":"X Xu","year":"2025","unstructured":"Xu X, Peng Q, Ren Z, Han Y, Jiang X, Wu Z, Tan S, Yang W, Oyang L, Luo X, Lin J, Xia L, Peng M, Wu N, Tang Y, Tian H, Zhou Y, Liao Q (2025b) CircRNF13 enhances IGF2BP1 phase separation-mediated ITGB1 mRNA stabilization in an m6A-dependent manner to promote oral cancer cisplatin chemoresistance. Mol Cancer 24(1):36. https:\/\/doi.org\/10.1186\/s12943-025-02239-4","journal-title":"Mol Cancer"},{"key":"10687_CR47","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1038\/s41388-020-01498-3","volume":"40","author":"Y Yan","year":"2020","unstructured":"Yan Y, Huang P, Mao K, He C, Xu Q, Zhang M, Liu H, Zhou Z, Zhou Q, Zhou Q, Ou B, Liu Q, Lin J, Chen R, Wang J, Zhang J, Xiao Z (2020) Anti-oncogene PTPN13 inactivation by hepatitis B virus X protein counteracts IGF2BP1 to promote hepatocellular carcinoma progression. Oncogene 40(1):28-45. https:\/\/doi.org\/10.1038\/s41388-020-01498-3","journal-title":"Oncogene"},{"key":"10687_CR140","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1007\/s10495-023-01903-8","volume":"29","author":"J Yan","year":"2024","unstructured":"Yan J, Wang X, Fan Z, Xu Y, Zhang Y, Liu Y, Guo L, Liu D (2024) Circ_0098823 binding with IGF2BP3 regulates DNM1L stability to promote metastasis of hepatocellular carcinoma via mitochondrial fission. Apoptosis 29(5-6):709-725. https:\/\/doi.org\/10.1007\/s10495-023-01903-8","journal-title":"Apoptosis"},{"key":"10687_CR54","doi-asserted-by":"publisher","first-page":"107248","DOI":"10.1016\/j.micpath.2024.107248","volume":"199","author":"S Yan","year":"2025","unstructured":"Yan S, Fu P, Zhu Y, Li H, Shan R, Gong B (2025) Whole transcriptome and proteome analyses identify ncRNAs and mRNAs to predict competing endogenous RNA networks in hepatitis B virus-induced hepatocellular carcinoma. Microbial Pathogenesis 199. https:\/\/doi.org\/10.1016\/j.micpath.2024.107248","journal-title":"Microb Pathog"},{"key":"10687_CR34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1186\/s13046-020-01714-8","volume":"39","author":"Z Yang","year":"2020","unstructured":"Yang Z, Wang T, Wu D, Min Z, Tan J, Yu B (2020) RNA N6-methyladenosine reader IGF2BP3 regulates cell cycle and angiogenesis in colon cancer. J Exp Clin Cancer Res 39(1):203. https:\/\/doi.org\/10.1186\/s13046-020-01714-8","journal-title":"J Exp Clin Cancer Res"},{"key":"10687_CR45","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1007\/s12072-022-10351-6","volume":"16","author":"L Yang","year":"2022","unstructured":"Yang L, Zou T, Chen Y, Zhao Y, Wu X, Li M, Du F, Chen Y, Xiao Z, Shen J (2022) Hepatitis B virus X protein mediated epigenetic alterations in the pathogenesis of hepatocellular carcinoma. Hepatology International 16(4):741-754. https:\/\/doi.org\/10.1007\/s12072-022-10351-6","journal-title":"Hep Intl"},{"key":"10687_CR144","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1186\/s12967-023-04235-y","volume":"21","author":"F Yang","year":"2023","unstructured":"Yang F, Ma Q, Huang B, Wang X, Pan X, Yu T, Ran L, Jiang S, Li H, Chen Y, Liu Y, Liang C, Ren J, Zhang Y, Wang S, Li W, Xiao B (2023) CircNFATC3 promotes the proliferation of gastric cancer through binding to IGF2BP3 and restricting its ubiquitination to enhance CCND1 mRNA stability. J Transl Med 21(1):402. https:\/\/doi.org\/10.1186\/s12967-023-04235-y","journal-title":"J Transl Med"},{"key":"10687_CR15","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/S0378-1119(01)00866-6","volume":"287","author":"K Yaniv","year":"2002","unstructured":"Yaniv K, Yisraeli JK (2002) The involvement of a conserved family of RNA binding proteins in embryonic development and carcinogenesis. Gene 287(1):49-54. https:\/\/doi.org\/10.1016\/S0378-1119(01)00866-6","journal-title":"Gene"},{"key":"10687_CR35","doi-asserted-by":"publisher","first-page":"e24514","DOI":"10.1002\/jcla.24514","volume":"36","author":"J Ye","year":"2022","unstructured":"Ye J, Chen X, Jiang X, Dong Z, Hu S, Xiao M (2022) RNA demethylase ALKBH5 regulates hypopharyngeal squamous cell carcinoma ferroptosis by posttranscriptionally activating NFE2L2\/NRF2 in an m(6) A-IGF2BP2-dependent manner. J Clin Lab Anal 36(7):e24514. https:\/\/doi.org\/10.1002\/jcla.24514","journal-title":"J Clin Lab Anal"},{"key":"10687_CR6","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12943-024-01994-0","volume":"23","author":"Y Ying","year":"2024","unstructured":"Ying Y, Wu Y, Zhang F, Tang Y, Yi J, Ma X, Li J, Chen D, Wang X, Liu X, Liu B, Luo J, Zheng X, Xie L (2024) Co-transcriptional R-loops-mediated epigenetic regulation drives growth retardation and docetaxel chemosensitivity enhancement in advanced prostate cancer. Molecular Cancer 23(1):79. https:\/\/doi.org\/10.1186\/s12943-024-01994-0","journal-title":"Mol Cancer"},{"key":"10687_CR102","doi-asserted-by":"publisher","first-page":"309","DOI":"10.23736\/S0026-4806.20.06653-7","volume":"113","author":"X Yu","year":"2022","unstructured":"Yu X, Zhao H, Cao Z (2022) The m6A methyltransferase METTL3 aggravates the progression of nasopharyngeal carcinoma through inducing EMT by m6A-modified Snail mRNA. Minerva Med 113(2):309-314. https:\/\/doi.org\/10.23736\/s0026-4806.20.06653-7","journal-title":"Minerva Med"},{"key":"10687_CR141","doi-asserted-by":"publisher","unstructured":"Zhang W, Zhu L, Yang G, Zhou B, Wang J, Qu X, Yan Z, Qian S, Liu R (2020) Hsa_circ_0026134 expression promoted TRIM25- and IGF2BP3-mediated hepatocellular carcinoma cell proliferation and invasion via sponging miR-127-5p. Biosci Rep 40(7). https:\/\/doi.org\/10.1042\/bsr20191418","DOI":"10.1042\/bsr20191418"},{"key":"10687_CR41","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1111\/liv.15251","volume":"42","author":"CH Zhang","year":"2022","unstructured":"Zhang CH, Cheng Y, Zhang S, Fan J, Gao Q (2022a) Changing epidemiology of hepatocellular carcinoma in Asia. Liver Int 42(9):2029-2041. https:\/\/doi.org\/10.1111\/liv.15251","journal-title":"Liver Int"},{"key":"10687_CR93","doi-asserted-by":"publisher","first-page":"215646","DOI":"10.1016\/j.canlet.2022.215646","volume":"535","author":"JY Zhang","year":"2022","unstructured":"Zhang JY, Du Y, Gong LP, Shao YT, Pan LJ, Feng ZY, Pan YH, Huang JT, Wen JY, Sun LP, Chen GF, Chen JN, Shao CK (2022b) ebv-circRPMS1 promotes the progression of EBV-associated gastric carcinoma via Sam68-dependent activation of METTL3. Cancer Lett 535:215646. https:\/\/doi.org\/10.1016\/j.canlet.2022.215646","journal-title":"Cancer Lett"},{"key":"10687_CR151","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41422-021-00581-y","volume":"32","author":"S Zhang","year":"2022","unstructured":"Zhang S, Huang W, Ren L, Ju X, Gong M, Rao J, Sun L, Li P, Ding Q, Wang J, Zhang QC (2022c) Comparison of viral RNA-host protein interactomes across pathogenic RNA viruses informs rapid antiviral drug discovery for SARS-CoV-2. Cell Res 32(1):9-23. https:\/\/doi.org\/10.1038\/s41422-021-00581-y","journal-title":"Cell Res"},{"key":"10687_CR94","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.4251\/wjgo.v16.i6.2555","volume":"16","author":"Y Zhang","year":"2024","unstructured":"Zhang Y, Zhou F, Zhang MY, Feng LN, Guan JL, Dong RN, Huang YJ, Xia SH, Liao JZ, Zhao K (2024) N6-methyladenosine methylation regulates the tumor microenvironment of Epstein-Barr virus-associated gastric cancer. World J Gastrointest Oncol 16(6):2555-2570. https:\/\/doi.org\/10.4251\/wjgo.v16.i6.2555","journal-title":"World J Gastrointest Oncol"},{"key":"10687_CR97","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/s00018-025-05604-0","volume":"82","author":"S Zhang","year":"2025","unstructured":"Zhang S, Gu M, Yin H, Pan S, Xie H, Chen W, Gul S, Zhao Y, Wang Z, Zheng W, You Y, You B (2025) IGF2BP1-HAX-1 positive feedback loop-mediated HAX-1 overexpression blocks autophagic flux and promotes chemoresistance in nasopharyngeal carcinoma. Cell Mol Life Sci 82(1):105. https:\/\/doi.org\/10.1007\/s00018-025-05604-0","journal-title":"Cell Mol Life Sci"},{"key":"10687_CR96","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1097\/CAD.0000000000001591","volume":"35","author":"C Zhao","year":"2024","unstructured":"Zhao C, Zhang F, Tian Y, Tang B, Luo J, Zhang J (2024) m6A reader IGF2BP1 reduces the sensitivity of nasopharyngeal carcinoma cells to Taxol by upregulation of AKT2. Anticancer Drugs 35(6):501-511. https:\/\/doi.org\/10.1097\/cad.0000000000001591","journal-title":"Anticancer Drugs"},{"key":"10687_CR98","doi-asserted-by":"publisher","first-page":"104677","DOI":"10.1016\/j.jbc.2023.104677","volume":"299","author":"ZQ Zheng","year":"2023","unstructured":"Zheng ZQ, Huang ZH, Liang YL, Zheng WH, Xu C, Li ZX, Liu N, Yang PY, Li YQ, Ma J, Sun Y, Tang LL, Wei D (2023) VIRMA promotes nasopharyngeal carcinoma, tumorigenesis, and metastasis by upregulation of E2F7 in an m6A-dependent manner. J Biol Chem 299(5):104677. https:\/\/doi.org\/10.1016\/j.jbc.2023.104677","journal-title":"J Biol Chem"},{"key":"10687_CR24","doi-asserted-by":"publisher","first-page":"5683","DOI":"10.1128\/JVI.00189-08","volume":"82","author":"Y Zhou","year":"2008","unstructured":"Zhou Y, Rong L, Lu J, Pan Q, Liang C (2008) Insulin-like growth factor II mRNA binding protein 1 associates with Gag protein of human immunodeficiency virus type 1, and its overexpression affects virus assembly. J Virol 82(12):5683-5692.","journal-title":"J Virol"},{"key":"10687_CR113","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.virol.2009.08.004","volume":"393","author":"Y Zhou","year":"2009","unstructured":"Zhou Y, Rong L, Zhang J, Aloysius C, Pan Q, Liang C (2009) Insulin-like growth factor II mRNA binding protein 1 modulates Rev-dependent human immunodeficiency virus type 1 RNA expression. Virology 393(2):210-220. https:\/\/doi.org\/10.1016\/j.virol.2009.08.004","journal-title":"Virology"},{"key":"10687_CR90","doi-asserted-by":"publisher","first-page":"e13373","DOI":"10.1111\/cpr.13373","volume":"56","author":"H Zhou","year":"2023","unstructured":"Zhou H, Jing S, Liu Y, Wang X, Duan X, Xiong W, Li R, Peng Y, Ai Y, Fu D, Wang H, Zhu Y, Zeng Z, He Y, Ye Q (2023) Identifying the key genes of Epstein-Barr virus-regulated tumour immune microenvironment of gastric carcinomas. Cell Prolif 56(3):e13373. https:\/\/doi.org\/10.1111\/cpr.13373","journal-title":"Cell Prolif"},{"key":"10687_CR9","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1186\/s40364-023-00499-0","volume":"11","author":"T-Y Zhu","year":"2023","unstructured":"Zhu T-Y, Hong L-L, Ling Z-Q (2023) Oncofetal protein IGF2BPs in human cancer: functions, mechanisms and therapeutic potential. Biomarker Research 11(1):62. https:\/\/doi.org\/10.1186\/s40364-023-00499-0","journal-title":"Biomark Res"},{"key":"10687_CR122","doi-asserted-by":"publisher","first-page":"e27631","DOI":"10.1016\/j.heliyon.2024.e27631","volume":"10","author":"X Zhu","year":"2024","unstructured":"Zhu X, Yu H, Li H, Zhang W, Sun L, Dou T, Wang Z, Zhao H, Yang H (2024) lncRNA SNHG1 promotes the progression of hepatocellular carcinoma by regulating the miR-7-5p\/IGF2BP2 axis. Heliyon 10(6):e27631. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e27631","journal-title":"Heliyon"},{"key":"10687_CR73","first-page":"1017","volume":"5","author":"F Ziemann","year":"2015","unstructured":"Ziemann F, Arenz A, Preising S, Wittekindt C, Klussmann JP, Engenhart-Cabillic R, Wittig A (2015) Increased sensitivity of HPV-positive head and neck cancer cell lines to x-irradiation \u00b1 Cisplatin due to decreased expression of E6 and E7 oncoproteins and enhanced apoptosis. Am J Cancer Res 5(3):1017-1031","journal-title":"Am J Cancer Res"}],"container-title":["Journal of Molecular Histology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10687-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10735-025-10687-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10735-025-10687-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:03:26Z","timestamp":1772003006000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10735-025-10687-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,10]]},"references-count":169,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["10687"],"URL":"https:\/\/doi.org\/10.1007\/s10735-025-10687-x","relation":{},"ISSN":["1567-2379","1567-2387"],"issn-type":[{"value":"1567-2379","type":"print"},{"value":"1567-2387","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,10]]},"assertion":[{"value":"14 October 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"34"}}